Meloxicam mitigated methylglyoxal-induced glycative stress in rats.
MEL has significantly mitigated the rats' MGO-induced cognitive, liver, and kidney impairments. Hence, it appears to be a potential molecule for repurposing as an antiglycation agent.
Authors
- Yamna Khurshid (ORCID: https://orcid.org/0000-0002-8553-0259)
- Ghulam Abbas (ORCID: https://orcid.org/0000-0001-6559-766X)
- Noor Ul Ain (ORCID: https://orcid.org/0000-0003-3097-2997)
- Talha Bin Fayyaz (ORCID: https://orcid.org/0000-0002-9453-186X)
- Syed Abid Ali (ORCID: https://orcid.org/0000-0003-0226-8257)
- Najeeb Khatian (ORCID: https://orcid.org/0000-0003-4423-0732)
- Shumaila Usman (ORCID: https://orcid.org/0000-0003-0506-5981)
- Uzair Nisar (ORCID: https://orcid.org/0000-0001-5956-0828)
- Hammad Ahmed (ORCID: https://orcid.org/0000-0002-7339-0690)
Institutions
- University of Karachi (PK)
- Jinnah Sindh Medical University (PK)
- International Center for Chemical and Biological Sciences (PK)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22038/ijbms.2025.83856.18143
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00